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Introduction
Centrioles are cylindrical subcellular structures found in eu-
karyotic cells that consist of nine sets of microtubules, generally 
triplets,  arranged  symmetrically  to  form  a  barrel-like  shape. 
They nucleate cilia and flagella and anchor the pericentriolar 
material (PCM) to form centrosomes, the principal microtubule- 
organizing centers in animal somatic cells. Centrosomes organize 
the interphase cytoskeleton and the bipolar mitotic spindle and 
thus contribute to the appropriate segregation of chromosomes 
during cell division (Nigg and Raff, 2009).
Centrins (caltractin) are small, highly conserved proteins 
that contain four calcium-binding helix-loop-helix EF hand 
domains. Originally identified as a major component of the 
calcium-responsive striated flagellar root structure in the green 
alga, Tetraselmis striata (Salisbury et al., 1984), centrins have 
been described in a wide range of eukaryotes, including mam-
mals (Huang et al., 1988; Lee and Huang, 1993; Ogawa and 
Shimizu, 1993; Errabolu et al., 1994). A centriolar localization 
of centrin was initially established in lower eukaryotes (McFadden 
et al., 1987; Salisbury et al., 1987, 1988; Salisbury, 1995), 
with subsequent work in mammalian cells localizing centrin 
to the PCM as well as to the distal lumen of centrioles (Baron 
et al., 1992; Paoletti et al., 1996). GFP-tagged centrin2 has 
become widely accepted as a robust marker for centrioles in 
live cells (White et al., 2000; Higginbotham et al., 2004; Kuriyama 
et al., 2007).
Four centrin isoforms have been described to date in mam-
malian cells. All are related to calmodulin, as was observed in 
the initial cloning of centrin from the biflagellated green alga, 
Chlamydomonas reinhardtii (Huang et al., 1988). Sequence 
analysis assigns them either to a subfamily related to budding 
yeast CDC31 or to one more homologous to the C. reinhardtii 
centrin (Middendorp et al., 1997, 2000). Centrin1 and centrin2 
are closely related to one another (Lee and Huang, 1993; Errabolu 
et al., 1994), with centrin2 being ubiquitously expressed and 
centrin1 being more restricted to male germ cells, neurons, and 
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he principal microtubule-organizing center in ani-
mal cells, the centrosome, contains centrin, a small, 
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gene targeting in the hyperrecombinogenic chicken DT40   
cell line to delete all three centrin genes in individual clones. 
Unexpectedly,  centrin-deficient  cells  underwent  normal 
cellular division with no detectable cell cycle defects. Light 
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difference  in  centrosome  composition  or  ultrastructure. 
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exacerbating the sensitivity of Cetn4/Cetn2 double mu-
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been described, along with a function for centrins in mRNA and 
protein export in yeast and vertebrates (Fischer et al., 2004;   
Resendes et al., 2008). A further role for centrins lies in nucleo-
tide excision repair (NER), a DNA repair process that acts to re-
move various base lesions from DNA, notably those induced by 
UV irradiation: 6–4 photoproducts and cyclobutane pyrimidine 
dimers (CPDs). There are two subpathways of NER: transcription- 
coupled NER, which acts rapidly to remove lesions that block 
transcription, and global genome repair, which is less rapid but 
can act genome wide. Centrin2 is found in a complex with the 
xeroderma pigmentosum group C (XPC) gene product, a com-
ponent of the DNA damage recognition complex of global ge-
nome repair (Sugasawa et al., 1998). Centrin helps to stabilize 
XPC in its complex with HRad23B (Araki et al., 2001). This 
occurs through direct interaction of centrin2 and XPC, with 
centrin2 stimulating NER in vitro (Nishi et al., 2005). Binding 
experiments have indicated that amino acids 847–866 in the 
C terminus of human XPC are sufficient for its interaction with 
centrin2 (Popescu et al., 2003; Nishi et al., 2005; Thompson et al., 
2006). Fibroblasts that express XPC mutants incapable of inter-
acting with centrin2 showed impaired resolution of UV-induced 
DNA damage (Nishi et al., 2005), and partial centrin knock-
down by RNAi delayed the clearance of 6–4 photoproducts in 
MCF-7 cells (Acu et al., 2010). Mutation of the Arabidopsis thali-
ana Cetn2 orthologue caused UV sensitivity and DNA repair 
defects, which were accompanied by a hyperrecombinogenic 
phenotype in a reporter assay (Molinier et al., 2004). Collec-
tively, these findings implicate centrins in multiple cellular 
activities away from the centrosome.
We are interested in the interplay between centrosomes 
and the DNA damage response (Dodson et al., 2004; Bourke   
et al., 2007). Disruption of centrosome duplication by centrin 
deletion appeared to be a useful approach to exploring how 
centrosomes are involved in controlling this response. Here, we 
show that ablation of all the centrins in a vertebrate cell line, the 
chicken lymphoma DT40, had no detectable effect on centrosome 
duplication or cell cycle progression. However, centrin-deficient 
cells were markedly sensitive to UV irradiation and required 
centrin for efficient DNA repair. Our results suggest that the 
principal functions of centrin lie in the noncentrosomal pool 
where most of the cellular content resides, with an important ca-
veat being that we were unable to use DT40 cells to assess centrin 
functions in ciliogenesis.
Results
We set out to define the roles of centrin by targeting centrin 
genes in chicken DT40 cells. As shown in Fig. S1 A, these pro-
teins are highly conserved between chicken and human. Data-
base analysis indicated the presence of three centrin loci in 
chicken cells. Using available genome information to compare 
these loci with their mammalian counterparts, we found that 
chicken Cetn2 and Cetn3 are syntenic with their human ortho-
logues, with a discontinuity 3 of the Cetn2 sequence between 
mammals  and  the  chicken.  Chicken  Cetn4  is  syntenic  with 
mammalian CETN4, which is a pseudogene in human cells. We 
found no centrin1-coding sequence in the region of chicken 
ciliated cells (Hart et al., 1999). CETN1 is believed to have 
arisen from a retrotransposition of the CETN2 transcript (Hart 
et al., 1999). Centrin3 is of the CDC31 subfamily and is also 
ubiquitously expressed (Middendorp et al., 1997). Cetn4 is an 
additional centrin2-related gene, with a tissue-restricted expres-
sion pattern that has suggested its being limited to ciliated cells 
(Gavet et al., 2003). All full-length centrin isoforms associate 
with centrioles, but to varying extents that may reflect differing 
activities of the centrins during centriole duplication and the 
formation of cilia (Laoukili et al., 2000; Gavet et al., 2003).
A recent evolutionary analysis of centrosomal proteins   
assigned centrin2 to a core group of proteins suggested to have 
been present in the ancestral centriolar structure (Hodges et al., 
2010). Consistent with this view of centrin functions, a require-
ment for centrin in centriolar activities has been described in a 
range of organisms. The budding yeast centrin orthologue Cdc31p 
is required for spindle pole body duplication (Baum et al., 1986; 
Huang et al., 1988). Knockdown of centrin in C. reinhardtii  
led to defects in the duplication and functioning of the flagellar 
basal  body,  a  structure  analogous  to  the  centriole  (Koblenz   
et al., 2003). Depletion of centrin in the water fern, Marsilea 
vestita, inhibited spermiogenesis by blocking basal body forma-
tion (Klink and Wolniak, 2001). Analysis of centrins in the 
multiciliated protozoan, Tetrahymena thermophila, revealed 
the localization of the CEN1 gene product to basal bodies and 
its requirement for their duplication, with other centrin gene 
products also localizing to basal bodies (Guerra et al., 2003; 
Stemm-Wolf et al., 2005). Ablation of centrin function by gene 
targeting in the pathogenic trypansosome, Leishmania donovani, 
caused defective basal body duplication, cell cycle arrest, and 
inhibition of proliferation at the amastigote stage accompanied 
by cell death, with a similar impact on cytokinesis seen with 
centrin knockdown in Trypanosoma brucei (Selvapandiyan   
et al., 2004, 2007).
Despite the importance of centrin function in ensuring 
centriole/basal body duplication throughout evolution (Salisbury, 
2007), its role is less clear in human cells. Although partial 
centrin3 depletion disrupted the radial organization of microtu-
bules in U2OS cells (Dammermann and Merdes, 2002), centri-
ole duplication was inhibited by RNAi depletion of centrin2 in 
HeLa cells (Salisbury et al., 2002). This treatment caused cen-
triole loss and a marked G1 phase cell cycle delay in nontrans-
formed hTERT-RPE1 cells (Mikule et al., 2007). However, in 
other experiments reported in HeLa cells, centrin2 depletion   
using the same siRNA sequence did not impact HsSAS-6 recruit-
ment to nascent procentrioles or the completion of centriole 
duplication,  although  centriole  assembly  rates  were  delayed 
(Strnad et al., 2007; Yang et al., 2010). siRNA depletion of cen-
trin2 and centrin3 using different inhibitory sequences had no 
impact on Plk4-induced centriole duplication in U2OS cells 
(Kleylein-Sohn et al., 2007).
Noncentrosomal  roles  for  centrins  have  also  been  de-
scribed, supporting the observation that the bulk of cellular 
centrin is not associated with centrioles (Paoletti et al., 1996). 
Recent data obtained in budding yeast implicate centrin in pro-
teasome activities (Chen and Madura, 2008), and an association 
between centrin2 and the vertebrate nuclear pore complex has 309 Centrin-deficient centrosomes • Dantas et al.
centrosome-associated kinase Aurora A, we saw no impact of 
centrin deficiency on centrosome composition during interphase 
(Fig. 2 A). In mitosis, we observed apparently normal spindle 
pole organization and cytokinetic midbody formation in cells that 
lacked any or all of the chicken centrin isoforms (Fig. 2 B). To 
verify these light microscopy observations at higher resolution, 
we performed EM. As shown in Fig. 2 C, centrioles in centrin- 
deficient cells were composed of nine triplet microtubules and were 
arranged orthogonally to one another. Centriole diameters were 
211.0 ± 13.6 nm (n = 42) in wild-type cells and 208.5 ± 17.0 nm 
(n = 34) in Cetn4/2/3-deficient cells, showing no impact of centrin 
deficiency on the characteristic ultrastructure of the centriole.
We also monitored the stages of centriole duplication in 
Cetn4/2/3-deficient cells using EM. Fig. 2 D shows that Cetn4/2/3-
deficient cells can form a cartwheel, that the procentriole dupli-
cates orthogonally to the mother, and that paired mother–daughter 
centrioles associate with one another. These analyses show that 
centrins are not essential for centrosome assembly.
To  test  whether  centrins  are  necessary  for  centrosome 
function in the mitotic spindle, we used EM to visualize micro-
tubule anchoring by centrin-deficient centrosomes. As shown in 
Fig. 3 A, centrin-deficient centrosomes can mature and form   
appendages that are capable of anchoring microtubules. Fig. 3 B 
shows that these microtubules establish links with mitotic chromo-
somes and establish mitotic spindles. Metaphase spindle lengths 
were 6.41 ± 0.59 µm (n = 55) in wild-type DT40 cells versus 
6.14 ± 0.57 µm (n = 53) in Cetn4/2/3-deficient cells, showing no 
significant difference. We then examined the capacity of centrin-
deficient centrosomes to organize microtubule regrowth after 
destabilization of the microtubules with combined cold and no-
codazole treatment. We found that Cetn4/2/3-deficient cells were 
as capable as wild-type cells of nucleating microtubule asters 
(Fig. 3 C). Probably the most demanding test of microtubule   
nucleation is forming a functional mitotic spindle. Analysis of 
the percentages of wild-type and Cetn4/2/3-deficient cells that 
entered G1 after release from a nocodazole arrest, where we saw 
no difference, provided further evidence for the ability of centrin-
deficient cells to nucleate microtubules efficiently (Fig. S3). For 
further analysis of mitosis, we used live cell imaging of cells 
stably transfected with an expression vector for histone H2B-
RFP to define the duration of mitosis in wild-type and Cetn4/2/3-
deficient cells. As shown in Fig. 3 D, the mean time taken from 
chromosome condensation to decondensation was 40.5 ± 10.6 
min in wild-type cells and 40.2 ± 9.5 min in Cetn4/2/3-deficient 
cells. These data indicate no mitotic impact of centrin deficiency 
and allow us to conclude that centrosomes are fully functional 
during mitosis in the absence of centrin.
We next examined the ability of centrin-deficient cells to 
produce multiple centrosomes. We used hydroxyurea (HU), ioniz-
ing radiation (IR), and Cdk1 inhibition, conditions under which 
cells are known to overduplicate their centrosomes (Balczon   
et al., 1995; Sato et al., 2000; Hochegger et al., 2007; Kleylein-
Sohn et al., 2007). We also tested the impact of UV irradiation 
and  observed  that  centrosome  amplification  arose  after  this 
genotoxic stress (Fig. 4, A and B). We found that Cetn4/2/3- 
deficient cells amplified their centrosomes under all conditions 
tested  (Fig.  4, A  and  B). To  confirm  that  the  structures  we 
chromosome 2 that is otherwise completely syntenic with the 
human chromosome 18 region that contains the putatively retro-
posed, single-exon CETN1 gene (Hart et al., 1999). Nor was any 
centrin1-coding sequence found in the corresponding region of 
the zebra finch (Taeniopygia guttata) genome. This suggests that 
the retroposition that generated CETN1 occurred after the bird–
mammal split of 310 million years ago (Reisz and Müller, 2004). 
All three centrins are expressed in DT40 cells and in chicken 
liver (Fig. 1 A), showing no tissue-restricted expression pattern.
To ablate centrin function, we used genomic PCR to generate 
targeting vectors that would delete the entire coding regions   
of Cetn4 and Cetn2 and all but the last two exons of Cetn3 
(Fig. S2, A–C) and transfected them into DT40 cells. We con-
firmed the successful targeting of the centrin loci using Southern 
analysis (Fig. S2, D–F). Our initial expectation had been that 
centrin loss would be lethal to cells, so we first targeted Cetn4, 
then Cetn2, and finally Cetn3, separately and in the same cell 
line. We then verified the loss of expression of the centrins using 
RT-PCR (Fig. S2 G) and immunoblotting using different anti-
bodies with broad species specificities for centrin1/2/4 and for 
centrin3 (Fig. 1 B). No full-length or truncated gene products 
were detected with any of the relevant antibodies. Immuno-
fluorescence microscopy confirmed the absence of all centrin 
isoforms in our Cetn4/2/3-deficient cells (Fig. 1 C).
There  is  a  second  centrinlike  sequence  adjacent  to  the 
chicken Cetn2 locus (LOC422304) that suggests a partial dupli-
cation of Cetn2 in the chicken genome. Although transcripts 
from LOC422304 can be found in the EST databases, their 5 
ends contain short ORFs that suggest that this is a pseudogene 
(Fig. S1 B). Even the longest possible ORF from LOC422304 
encodes  a  predicted  protein  that  lacks  the  centrin-diagnostic   
N-terminal region including part of the first EF hand and that is 
predicted to have low homology to other centrins at the C terminus. 
We cloned the sequence expressed from LOC422304 from DT40 
cells by RT-PCR and expressed a myc-tagged version of the   
longest  ORF  available  in  wild-type  and  Cetn4/2/3-deficient 
DT40 cells. As shown in Fig. S1 C, Myc-LOC422304p localized 
to centrosomes in wild-type cells but not in centrin-deficient 
cells,  demonstrating  that  any  centrosome  localization  of  this 
gene product is dependent on endogenous centrin. Finally, as we 
saw no detectable signal in Cetn4/2/3-deficient DT40 cells using 
four different anti-centrin antibodies (Fig. 1 B), we conclude 
that LOC422304 does not encode a functional centrin.
We next monitored the proliferative capacity of centrin- 
deficient cells. As shown in Fig. 1 D, cells that lacked any centrin 
genes proliferated slightly more slowly than wild-type cells, with 
the Cetn4/2/3-deficient cells proliferating the slowest. However, 
this was not accompanied by any pronounced cell cycle delay, as 
determined by flow cytometry for BrdU incorporation (S phase) 
or histone H3 phosphorylation (M phase) and microscopy analy-
sis of the proportion of the population undergoing cytokinesis 
(Fig. 1 E and not depicted). From these data, we concluded that 
centrins are dispensable for the viability of DT40 cells.
We then used microscopy to examine the impact of cen-
trin deficiency on the centrosome. Using antibodies specific 
for the centriole components Cep135, Ninein, and Cep76, the 
PCM components pericentrin, -tubulin, and PCM1, and the   JCB • VOLUME 193 • NUMBER 2 • 2011   310
Figure 1.  Centrin-deficient DT40 cells are viable and show no proliferative defect. (A) RT-PCR analysis of expression of the indicated genes in wild-type 
(WT) and centrin-deficient DT40 cells and in chicken liver. (B) Immunoblot of centrin in cells of the indicated genotype. Numbers refer to the centrin mutant 
in each lane. Antibodies used for these analyses are indicated. (C) Immunofluorescence microscopy analysis of wild-type and centrin-targeted DT40 cells 
stained with antibodies to the indicated centrin orthologue (green) with -tubulin (red) as a reference marker. Cells were counterstained with DAPI to visual-
ize the DNA (blue) before imaging. Insets show magnifications as indicated in the main images. Bars: 5 µm; (inset) 0.5 µm. (D) Proliferation analysis of 
cells of the indicated genotype. Data points show mean ± SD of the results from at least three separate experiments. Doubling times were 7 h 42 min ± 
28 min for wild type and 9 h 18 min ± 13 min for Cetn4/2/3-deficient cells. (E) FACS plot of cell cycle distributions in asynchronous cells of the indicated 
genotype. The G1 (bottom left), S (top), and G2/M (bottom right) gates are indicated in blue, and the numbers refer to the percentage of cells detected in 
each of the gates averaged from two separate experiments.311 Centrin-deficient centrosomes • Dantas et al.
Figure 2.  Structural integrity of centrin-deficient centrosomes. (A) Immunofluorescence microscopy analysis of wild-type and the indicated Cetn-targeted 
DT40 cells stained with antibodies to the indicated centrosome component (green) with -tubulin (red) as a reference marker. Cells were counterstained with 
DAPI to visualize the DNA (blue) before imaging. Bar, 5 µm. (B) Immunofluorescence micrograph of centrosomes in mitotic cells of the indicated genotype 
stained as in A but with -tubulin (red) as the control. Bar, 5 µm. (C) Transmission electron micrographs of centrosomes in cells of the indicated genotype. 
Bars, 100 nm. (D) TEM comparison of different stages of centrosome cycle in wild-type and centrin-deficient cells. Bars, 100 nm.JCB • VOLUME 193 • NUMBER 2 • 2011   312
counted  were,  in  fact,  centrosomes,  we  also  performed  EM 
analyses and observed multiple centrioles in both wild-type and 
Cetn4/2/3-deficient cells that had been irradiated (Fig. 4 C). 
These findings show that centrin levels are not limiting for centro-
some amplification after DNA damage or cell cycle delay.
The elevated levels of centrosome amplification seen in 
centrin-deficient cells after irradiation suggested some problems 
in dealing with genotoxic stress. To determine whether centrin 
plays a role in DNA damage responses, we performed clono-
genic survival assays. As shown in Fig. 5 A, Cetn4/2/3-deficient 
cells were no more sensitive than wild-type cells to IR. How-
ever, loss of Cetn4 and Cetn2 caused a pronounced sensitivity 
to UV treatment, which was exacerbated by the further loss of 
Cetn3 (Fig. 5 B). Although no role for centrin3 in the repair 
of UV-induced DNA damage has been established, the known 
interaction of human centrin2 with XPC (Araki et al., 2001) 
suggests that this sensitivity arises from defective NER. Impor-
tantly, this hypersensitivity to UV irradiation was suppressed by 
transgenic expression of either Cetn4 or Cetn2 and partially res-
cued by Cetn3 expression (Fig. 5 C), demonstrating a require-
ment for the chicken centrin2 orthologues and novel potential 
involvement of centrin3 in dealing with UV irradiation.
We next tested whether the sensitivity of centrin-deficient 
cells to UV treatment was caused by a defect in checkpoint ac-
tivation. As shown in Fig. 6 A, the UV-responsive activation of 
Chk1, as determined by its phosphorylation, occurred with the 
same kinetics in wild-type and Cetn4/2/3-deficient cells. How-
ever, the resolution of this phosphorylation signal to normal 
levels took longer in Cetn4/2/3-deficient cells, with the bulk of 
the phosphorylation being removed by 12 h in wild-type cells, 
but not in centrin-deficient cells (Fig. 6 A). Cell cycle analysis 
of the response to UV showed a profile consistent with an at-
tenuated resolution of DNA damage signaling, with the major-
ity of wild-type cells showing an S phase delay by 9 h before 
accumulating with a 2C DNA content at 12 h and the Cetn4/2/3-
deficient population showing the S phase delay only by 12 h 
(Fig. 6 B). An elevated level of cell death was also evident in 
the centrin-deficient population compared with wild-type cells 
from 18 h after treatment, consistent with the results obtained 
in the clonogenic survival assay. To examine the potential cause 
of the extended DNA damage signaling, we used an immunodot- 
blot  experiment  to  monitor  the  kinetics  with  which  DNA   
damage (CPDs) formed and was repaired after UV irradiation. 
Figure  3.  Normal  microtubule  nucleation  functions  of  centrin-deficient 
centrosomes. (A) Transmission electron micrographs of microtubule anchor-
age at the centrosomes in cells of the indicated genotype. Bar, 500 nm. 
(B) Transmission electron micrographs of spindle microtubule association 
with chromosomes in cells of the indicated genotype. Bars, 500 nm. 
(C) Immunofluorescence microscopy analysis of microtubule nucleation in 
DT40 cells before and after release from 1-h arrest in 1 µg/ml nocodazole 
at 4°C. Cells were stained with antibodies to -tubulin (green) with   
-tubulin (red) as a centrosomal marker. Cells were counterstained with 
DAPI to visualize the DNA (blue) before imaging. Bar, 5 µm. (D) Quan-
titation of the percentage of cells with aster nucleation after microtubule 
regrowth for 1 min at 39.5°C. Histogram shows mean ± SD of three sepa-
rate experiments in which at least 200 cells per experiment were counted. 
(E) Duration of mitosis in centrin-deficient cells. Cells of the indicated geno-
types that stably expressed histone H2B-RFP were imaged by time-lapse 
microscopy, and the time taken from chromosome condensation to de-
condensation was assessed. Data show mean ± SD for the 70 individual 
cells analyzed as data points.
 313 Centrin-deficient centrosomes • Dantas et al.
As shown in Fig. 6 (C and D), UV treatment induces a rapid and 
massive increase in CPDs, returning to basal levels 24 h after 
irradiation. Cetn4/2/3-deficient cells are much slower to repair 
the UV-induced lesions, with a notable fraction of the induced 
damage remaining at 24 h after treatment. Notably, transgenic 
expression of any of the chicken centrins greatly improved the 
null cells’ ability to repair UV-induced DNA damage (Fig. 6,   
C and D). These data demonstrate that vertebrate centrins are 
necessary for the efficient repair of UV-induced DNA damage 
and that all three centrins are potentially involved in such repair.
Discussion
The viability of centrin-deficient DT40 cells and the integrity of 
their  centrosomes  were  unexpected,  given  the  wide-ranging   
requirement for centrins in centriole/basal body duplication 
throughout evolution. Even though p53-dependent responses are 
blunted in DT40 cells, so that the p21–p53 checkpoint-driven 
Figure  4.  Efficient  DNA  damage–induced  centrosome  amplification  in 
centrin-deficient cells. (A) Immunofluorescence microscopy analysis show-
ing centrosome amplification in wild-type and the indicated Cetn-targeted 
DT40 cells stained with antibodies to glutamylated tubulin (green) and 
-tubulin (red) at 24 h after treatment with 10 Gy IR. Cells were counter-
stained with DAPI to visualize the DNA (blue) before imaging. Bar, 5 µm. 
(B) TEM comparison of amplified centrosomes in wild-type and centrin- 
deficient cells, seen 24 h after 10 Gy IR. Bar, 500 nm. (C) Quantitation 
of cells of the indicated genotype with aberrant centrosome numbers 24 h 
after 5-J/m
2 UV-C treatment (+UV) or 10 Gy IR (+IR) and after 24-h incu-
bation with 4 mM HU (+HU) or 6 µM RO3306 (+RO). Histogram shows 
mean ± SD of three separate experiments in which at least 300 cells per 
experiment were counted.
Figure 5.  Hypersensitivity to UV irradiation of centrin-deficient cells and 
rescue by expression of centrins 4, 2, or 3. (A) Clonogenic survival assay 
of cells of the indicated genotype treated with the indicated doses of IR. 
Data points show mean ± SD of the surviving fractions in at least three 
separate experiments. (B) Clonogenic survival assay of cells of the indi-
cated genotype treated with the indicated doses of UV-C irradiation. Data 
points show mean ± SD of the surviving fractions in at least three separate 
experiments.  (C)  Cetn4/2/3-deficient  cells  that  were  stably  transfected 
with the indicated myc-centrin–expressing transgenes were analyzed by 
clonogenic survival assay. Survival curves show mean ± SD of the surviv-
ing fractions in at least three separate experiments.JCB • VOLUME 193 • NUMBER 2 • 2011   314
It has been reported that HU-induced centrosome amplifi-
cation was suppressed when XPC was overexpressed, and, thus, 
centrin sequestered in the nucleus of MDA-MB-231 cells (Acu 
et al., 2010). Furthermore, Cetn2 knockdown prevented the cen-
triole overduplication that is normally driven by the overexpres-
sion of nondegradable Mps1 kinase (Yang et al., 2010). Although 
we saw no evidence that centrin was rate limiting for the over-
duplication of centrosomes caused by several genotoxic treatments, 
a possible reason for the difference between our observations and 
those reported is that the movement of centrin between the 
cytoplasm and the nucleus may be involved in the generation of 
additional centrioles in response to certain conditions that do 
not use the original centrosome as a template, such as after HU 
treatment. A model in which nuclear centrin–containing precur-
sors initially assemble in the nucleus has been suggested as one 
mechanism for centriole overduplication (Prosser et al., 2009), 
with such aggregates being termed “precentrioles” in the de novo 
arrest  described  after  the  loss  of  centrosome  components   
(Mikule et al., 2007) was not anticipated, our prediction had 
been that we would see the inhibition of centriole duplication 
seen in RNAi experiments in HeLa cells (Salisbury et al., 2002). 
However,  consistent  with  the  robust  centrosome  structures 
and activities we saw in centrin-deficient DT40 cells, siRNA 
depletion of centrin2 in HeLa cells did not impact HsSAS-6   
recruitment  to  nascent  procentrioles  or  centriole  duplication 
(Strnad et al., 2007; Yang et al., 2010), and similarly, Plk4- 
induced centriole duplication in U2OS cells occurred efficiently 
despite  siRNA  depletion  of  centrin2  or  centrin3  (Kleylein- 
Sohn et al., 2007). The fact that we have used gene targeting 
to ablate centrin function allows us to exclude any potential 
artifact arising from incomplete gene knockdown or off-target 
effects. Our current data do not indicate a requirement for   
vertebrate centrins in centriole duplication or mitotic centro-
some function.
Figure 6.  Defective NER in centrin-deficient cells. (A) Immunoblot analysis of Chk1 phosphorylation in cells of the indicated genotype was performed 
before or at different times after 3-J/m
2 UV-C treatment, using anti–phospho-Chk1 S345 with monoclonal mouse anti-Chk1 as loading control. (B) Flow 
cytometry analysis of the DNA content of wild-type and Cetn4/2/3-deficient cells before or at the indicated times after 3-J/m
2 UV-C treatment. (C) Immunodot-blot 
analysis of CPDs in genomic DNA from wild type, Cetn4/2/3-deficient cells, and Cetn4/2/3-deficient cells that were stably transfected with the indicated 
centrin-expressing transgenes (C4, C2, and C3) before or at the indicated times after 5-J/m
2 UV-C treatment. Time 0 is immediately after irradiation.   
(D) Quantitation of the kinetics of CPD repair in cells of the indicated genotype after 5-J/m
2 UV-C treatment. Data show mean ± SD of the CPD signal 
normalized to time 0 signals in at least three separate experiments in which each sample was blotted in triplicate.315 Centrin-deficient centrosomes • Dantas et al.
centriole assembly pathway that generates centrioles after laser 
ablation of the preexisting structures (La Terra et al., 2005).   
In terms of templated centriole duplication, we have previously 
suggested that DNA damage–induced centrosome amplification   
occurs during an extended G2 arrest (Dodson et al., 2004; Inanç 
et al., 2010). The elevated UV-induced centrosome amplification 
seen in centrin-deficient cells thus can be attributed to the ex-
tended DNA damage–induced cell cycle delay. The absence of 
any deficiency in the response to IR in centrin-null cells makes 
the IR-induced centrosome overamplification difficult to explain. 
Up-regulation of Cdk activity after IR is a potential mechanism of 
centrosome amplification (Bourke et al., 2010). As centrin can be 
phosphorylated in vitro by Cdk1 (Lutz et al., 2001), it is possible 
that the deletion of centrins may enhance the activity of Cdks on 
other substrates that drive centrosome overduplication.
An expanding body of work implicates the centrosome as 
a hub for DNA damage response signaling, with a wide range of 
DNA repair and checkpoint proteins localizing to the centro-
some (Löffler et al., 2006). The sensitivity of centrin-deficient 
DT40 cells to UV and their defect in resolving CPDs are consis-
tent with several studies linking centrin2 with NER through its 
interaction with XPC (Araki et al., 2001; Popescu et al., 2003; 
Nishi et al., 2005). Making this role of centrins more general,   
a cdc31 mutant that affects Cdc31p binding of the yeast XPC 
orthologue, Rad4, is UV sensitive (Chen and Madura, 2008), 
and an interaction has been described between RAD4 and 
CENTRIN2 in A. thaliana (Liang et al., 2006). Nuclear local-
ization of centrin2 is driven by XPC (Charbonnier et al., 2007). 
Centrin2 is modified by SUMO2/3, and its efficient binding to 
XPC and localization to the nucleus depend on SUMOylation 
activity (Klein and Nigg, 2009). A recent study by Acu et al. 
(2010) demonstrated that centrin2 relocalization to the nucleus 
after HU treatment is dependent on XPC. Furthermore, Acu et al. 
(2010) also observed delayed resolution of UV-induced 6–4 
photoproducts where centrin2 was partially depleted in human 
MCF-7 cells using short hairpin RNA. As the knockdown of 
centrin2 was toxic in these cells, it was possible that the delayed 
resolution of DNA damage might not be attributable to an NER 
defect alone. However, the UV hypersensitivity and DNA repair 
deficiency seen in our centrin knockout cells provide robust evi-
dence for a function of vertebrate centrins in NER. Interestingly, 
another centrosomal protein, Cep164, has also been implicated 
directly in NER (Pan and Lee, 2009), so further examination of 
the interplay between the centrosome and NER is warranted.
Four potential explanations for the high level of centrin 
conservation are compatible with our observations. The first is 
that there exists cell type– or developmental stage–specific   
requirements for centrins in centriole duplication. Differing 
effects of centrin2 overexpression were observed in various   
human cell lines (Yang et al., 2010), but the ubiquity of centrin2 
and centrin3 expression suggests a more general role for the 
centrins. Second, a further possible centrosomal function for 
centrins is that of establishing a primary cilium. As DT40 cells 
are lymphocytes and thus do not bear primary cilia (Alieva and 
Vorobjev, 2004), we are unable to examine this activity directly. 
Although the absence of normal primary cilia in several human 
genetic disorders is not cell lethal (Goetz and Anderson, 2010), 
a role for centrins in ciliogenesis may nevertheless provide evo-
lutionary pressure for centrin conservation in terms of the whole 
organism. A third possibility is that centrins play a predomi-
nantly regulatory role in the control of centriole duplication or 
functioning that is dispensable during the cell cycle. Ser170 
phosphorylation of centrin2 occurs early during mitosis, and, 
when stimulated during interphase by increased protein kinase A 
activity, such phosphorylation was accompanied by centriole 
separation (Lutz et al., 2001). Centrin2 has been described as an 
Mps1 substrate, and recent work implicated the three Mps1 target 
sites identified in the control of centriole duplication (Yang et al., 
2010). In keeping with a regulatory role, overexpression of cen-
trin drives centriole overduplication (Yang et al., 2010). The final 
possibility for the evolutionary pressure that has maintained the 
high degree of conservation in centrin sequences is that their key 
role in the cell is not at the centrosome. Although centrins are 
sufficiently conserved to have been present in the last common 
ancestor of the eukaryotes (Hodges et al., 2010), their presence in 
other ancient cellular structures such as the nuclear pore may in-
dicate coevolution with macromolecular complexes other than 
the centrosome (Neumann et al., 2010). Centrin activities in NER 
and the observation that the bulk of the cellular centrin is not at 
the centrosome (Paoletti et al., 1996) provide support for this 
view. Gene-targeting experiments in mammals may allow the 
resolution of these various possibilities in the entire organism.
Materials and methods
Cloning
Genomic sequences for the Cetn-targeting arms were amplified by PCR 
with KOD Hot Start (EMD), cloned into pGEM-T Easy (Promega), and se-
quenced. The following primer sets and strategies were used: Cetn4 5 arm 
(5-GCACAGGCTTGCTGAAAGGATGCACTGC-3 and 5-CTGCTTGCG-
GCCGCACCGCGCCGGGATC-3) and 3 arm (5-GGATCCGATTTGTT-
GCCTTACAGCTGTTCC-3  and  5-CAGTATCCATTCCAGCCTTGCCTT-
GAGT-3).  An  NdeI–ScaII  fragment  containing  the  5  arm  was  cloned 
using AatII–ScaII sites upstream of the 3 arm and histidinol and blasticidin 
resistance cassettes inserted into a BamHI site. PvuI and SalI digests were 
used for linearization of the completed targeting vectors.
We  also  used  Cetn2  5  arm  (5-CCTAAGAATCCGGAGCCAC-
CAATCA-3 and 5-TGCTCAACACTACCCTTCCCCATTG-3) and 3 arm 
(5-GGATCCGTTGCTTGTTTGCTGCGCTCGTAAG-3  and  5-GTCGACT-
GCCTTTATTCACCTCACGCACAGG-3). A NotI–BamHI fragment contain-
ing the 5 arm was cloned with a BamHI–SalI fragment containing the 3 
arm into pBluescript II SK. LoxP-puromycin (Arakawa et al., 2001) and 
hygromycin resistance cassettes were inserted into the BamHI site, and a 
NotI digest was used for linearization.
Lastly, we used Cetn3 5 arm (5-CTTTGTGCAACGGCTCATTGTC-3 
and  5-GGATCCAGACTACTGCGCTGCCACTCAAG-3)  and  3  arm   
(5-GGATCCGCAGCTTGACCAGGAGTACTTTG-3 and 5-TGAAGGG-
TAAACTCAGAATGACAGA-3). The 5 arm was cloned as a SpeI–BamHI 
fragment upstream of the 3 arm in pGEM-T Easy. LoxP-puromycin and 
loxP-neomycin resistance cassettes were cloned into the BamHI site, and 
MluI digests were used for linearization.
For cDNA cloning, RNA was extracted from DT40 cells and chicken 
liver using TRI reagent (Invitrogen). Reverse transcription was performed 
using SuperScript First-Strand (Invitrogen) and PCR with KOD Hot Start. 
cDNAs were cloned into the pGEM-T Easy, sequenced, and then subcloned 
into pCMV-3Tag-2 (Agilent Technologies). The primers used to amplify cDNA 
were as follows: Cetn4 (5-CGGAATTCGATGGCGTCCAACTATAGA-3 and 
5-CGGGATCCCTAATATAAGCTCGTTTTCTT-3),  Cetn2  (5-GAAGATCTTC-
TATGGCCTCCAGCTTCAAGAAG-3 and 5-CGGGATCCTCAGTAAAGGCT 
GGTCTTCTTC-3), Cetn3 (5-CGGAATTCGATGAGCGTGTGAAGGGG-3 
and 5-CGGGATCCTTAAATATCTCCAGTCATAATAG-3), and LOC422304 
(5-GAATTCTATGGTGAGGCCCGCTGGGCAC-3 and 5-TCTAGATTA-
CAGGTCAGTCAATGTCAGAATC-3). All expression constructs, including JCB • VOLUME 193 • NUMBER 2 • 2011   316
Microtubule regrowth assays
DT40 cultures were treated with 1 µg/ml nocodazole for 3 h, incubated for an 
additional hour on ice, and subsequently spun down at 250 g for 5 min and 
washed three times in ice-cold PBS for 15 min each. Cells were adhered to 
poly-l-lysine slides for 30 min at 4°C, submerged in PBS/1% FCS at 40°C for   
1 min, and immediately fixed in methanol. Immunofluorescence microscopy 
with antibodies to - and -tubulin was then used to assess microtubule growth.
EM
DT40 cells were processed for transmission EM (TEM) using an established 
protocol (Liptrot and Gull, 1992) in which they were pelleted at 250 g for   
5 min and fixed with a combination of 2% glutaraldehyde and 2% PFA in   
0.1 M cacodylate buffer. After posfixation in a solution of 2% osmium   
tetroxide/0.1 M cacodylate buffer, pH 7.2, cell pellets were dehydrated 
through a graded series of ethanol (30, 60, 90, and 100%) that was then 
replaced by propylene oxide. Subsequently, cell pellets were embedded in 
Agar Low Viscosity Resin. Sections were cut on a microtome (Reichert-Jung   
Ultracut E; Leica), stained with uranyl acetate and lead citrate, and then 
viewed on an electron microscope (H-7000; Hitachi). Images were taken 
with a camera (ORCA-HRL; Hamamatsu Photonics) and processed using 
AMT version 6 (AMT Imaging).
Immunoblotting experiments
Whole-cell extracts were prepared with radioimmunoprecipitation assay buf-
fer  (50  mM  Tris-HCl,  pH  7.4,  1%  NP-40,  0.25%  sodium  deoxycholate,   
150 mM NaCl, 1 mM EDTA, and protease inhibitor cocktail). Proteins were 
transferred to nitrocellulose membranes for analysis using the following pri-
mary  antibodies:  rabbit  anti-centrin2  (poly6288;  BioLegend)  at  1:1,000; 
monoclonal anti-centrin3 (3E6; Abnova) at 1:1,500; rabbit anti-centrin2 and 
anti-centrin3 at 1:1,500 and 1:250, respectively (C2 and C3; gifts from   
M. Bornens, Institut Curie, Paris, France; Laoukili et al., 2000); anti–phospho-
Chk1 S345 (Cell Signaling Technology) at 1:500; anti-Chk1 (Cell Signaling 
Technology) at 1:1,000; anti-thymine dimer antibody (H3/ab10347; Abcam) 
at 1:1,000; and anti–-tubulin (B512; Sigma-Aldrich) at 1:5,000.
Flow cytometry
Cells were fixed with 70% ice-cold ethanol overnight at 4°C, washed in 
PBS, and incubated in 40 µg/ml propidium iodide and 200 µg/ml RNase 
A in PBS for 1 h. Where indicated, cells were cultured with 20 µM   
5-bromo-2’-deoxydine for 15 min. After fixation in 70% ice-cold ethanol 
overnight at 4°C, cells were washed in PBS with 1% BSA, treated with 2 M 
HCl/0.5% Triton X-100 for 30 min at 37°C, and washed again. Cells 
were  then  incubated  with  30%  anti-BrdU  (B44;  BD)  in  PBS  with  1% 
BSA/0.5% Triton X-100 for 1 h with shaking at 37°C followed by washing 
and  incubation  with  FITC-conjugated  anti–mouse  (Jackson  ImmunoRe-
search Laboratories, Inc.) at 1:50 in PBS with 1% BSA. Finally, cells were 
resuspended in propidium iodide/RNase A solution as described previ-
ously. Flow cytometry was performed on a FACSCalibur (BD).
Immunodot-blot analysis
Cells were harvested after 3-J/m
2 UV-C irradiation and washed in PBS, and 
genomic DNA was extracted using a Genomic DNA Miniprep kit (Sigma- 
Aldrich).  DNA  was  quantified  using  a  spectrophotometer  (NanoDrop 
2000c; Thermo Fisher Scientific). Triplicates of 250 ng DNA from each time 
point were denatured in 0.3 M NaOH at 60°C for 1 h, cooled on ice, and 
neutralized in 2× salt–sodium citrate buffer. Samples were then transferred 
to a nylon membrane (Hybond-N; GE Healthcare) using a microfiltration dot-
blot apparatus (model 170-6545; Bio-Rad Laboratories). The membrane 
was then baked at 80°C for 1 h, immunoblotted with thymine dimer anti-
body,  and  visualized  with  HRP-conjugated  secondary  antibody.  Signals 
were acquired using an Imager (LAS-3000; Fujifilm), quantified with Multi-
Gauge v.2.2 (Fujifilm), and normalized to time 0 after UV-C irradiation.
Online supplemental material
Fig. S1 shows the conservation of the centrin proteins between human and 
chicken and the analysis of LOC422304. Fig. S2 shows the gene-targeting 
strategies for the three chicken centrins with their respective diagnostic 
Southern blots and RT-PCR results. Fig. S3 shows the integrity of spindle   
assembly checkpoint and robust recovery in Cetn-deficient cells after nocoda-
zole treatment and washout. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201012093/DC1.
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pmRFP-N1-H2B (Dodson et al., 2007), were linearized with MluI or ApaLI 
before transfection into DT40 cells.
Cell culture and gene targeting
DT40 cells were cultured as described in RPMI media (Lonza) and supple-
mented with 10% fetal calf serum (Lonza), 1% chicken serum (Sigma- 
Aldrich), and 1% penicillin/streptomycin (Sigma-Aldrich) at 39.5°C with 
5% CO2 (Takata et al., 1998). Electroporations for gene targeting were 
performed using 15 µg of linearized and purified DNA and 300 V/600 µF 
or 550 V/25 µF in a GenePulser (Bio-Rad Laboratories), as previously de-
scribed (Takata et al., 1998). Cells were transiently transfected with 5 or 
15 µg endotoxin-free plasmid DNA using nucleofection (program B-23; 
Lonza). Clonogenic survival assays were performed as described previously 
(Takata et al., 1998), using irradiation with a 
137Cs source at 23.5 Gy/min 
(Mainance Engineering). For UV-C irradiation, cells were irradiated in PBS 
using a 254-nm UV-C lamp at 23 J/m
2/min (NU-6 lamp; Benda). Unless 
otherwise stated, cell culture reagents were purchased from Sigma-Aldrich. 
Cdk1 Inhibitor IV (RO-3306; EMD) was dissolved in DMSO. Selection 
with antibiotics was with 1 mg/ml histidinol, 25 µg/ml blasticidin (Invivo-
Gen),  2.5  mg/ml  hygromycin  (InvivoGen),  0.5  µg/ml  puromycin,  and   
2 mg/ml geneticin (Invitrogen).
DT40 cells were targeted sequentially to generate Cetn4
/, Cetn4
/ 
Cetn2
/,  and  finally  the  triple  knockout  Cetn4
/Cetn2
/Cetn3
.  
A separate triple knockout was generated after transiently expressing Cre 
recombinase (Arakawa et al., 2001) in Cetn4
/Cetn2
/ cells to remove 
the puromycin resistance cassette. The Cetn3 locus was then targeted with 
the puromycin construct.
Immunofluorescence microscopy
Cells were left to attach to poly-l-lysine–coated slides for 15 min and then 
plunged into 95% methanol with 5 mM EGTA (prechilled to –20°C) for   
10 min. Alternatively, cells were fixed in 4% PFA for 10 min and permeabi-
lized in 0.15% Triton X-100 in PBS for 2 min. Thereafter, the cells were 
blocked in 1% BSA in PBS and incubated with primary antibodies for 1 h 
at 37°C followed by a 45-min incubation at 37°C with secondary antibodies. 
Secondary  antibodies  were  labeled  with  FITC  and  Texas  red  (Jackson   
ImmunoResearch Laboratories, Inc.). Slides were mounted with DABCO 
(2.5% DABCO [Sigma-Aldrich], 50 mM Tris-HCl, pH 8, and 90% glycerol) 
and supplemented with 1 µg/ml DAPI. Cells were imaged at 37°C on an 
integrated microscope system (DeltaVision) controlled by SoftWorx soft-
ware (Applied Precision) mounted on a microscope (IX71; Olympus) with 
a PlanApo N100× oil objective (NA 1.40). Images were taken using a 
camera (CoolSnap HQ2; Photometrics) and deconvolved in SoftWorx using 
the ratio method, and maximal intensity projections were saved as Photo-
shop CS version 8.0 files (Adobe Systems). Cell counting was performed 
with a microscope (BX51; Olympus), using 60× oil (NA 1.4) and 100× oil 
(NA 1.35) objectives.
The primary antibodies used in this study and their dilutions were as 
follows: mouse monoclonal anti–Aurora A (35C1; Abcam) at 1:500; rab-
bit polyclonal anti-centrin2 (poly6288; BioLegend) at 1:250; monoclonal 
anti-centrin3 (3E6; Abnova) at 1:1,000; rabbit anti-Cep76 (a gift from   
W. Tsang and B. Dynlacht, New York University School of Medicine, New 
York, NY; Tsang et al., 2009) at 1:200; mouse anti-Cep135 (a gift from   
R. Kuriyama, University of Minneapolis, Minneapolis, MN; Ohta et al., 
2002) at 1:1,000; mouse anti–myc 9E10 at 1:1,000; rabbit polyclonal 
anti-ninein  (ab4447;  Abcam)  at  1:100;  rabbit  polyclonal  anti–PCM-1 
(817; a gift from A. Merdes, Centre National de la Recherche Scientifique 
and  Laboratoires  Pierre  Fabre,  Toulouse,  France;  Dammermann  and 
Merdes, 2002) at 1:5,000; rabbit polyclonal anti-pericentrin (ab4448; 
Abcam) at 1:100; mouse monoclonal anti–-tubulin (B512; Sigma-Aldrich) 
at 1:2,000; mouse monoclonal anti–-tubulin (GTU88; Sigma-Aldrich) at 
1:150; anti–-tubulin (C-20; Santa Cruz Biotechnology, Inc.) at 1:250; 
mouse monoclonal anti-glutamylated tubulin (GT335; a gift from C. Janke, 
Institut Curie, Paris, France; Wolff et al., 1992) at 1:300; and rabbit poly-
clonal anti-survivin (WCE43D; a gift from B. Earnshaw, Wellcome Trust 
Centre for Cell Biology, Edinburgh, Scotland, UK; Yue et al., 2008) at 
1:300. Labeled secondary antibodies were purchased from Jackson Immuno-
Research Laboratories, Inc.
Live cell imaging
For live cell imaging, cells that stably expressed H2B-RFP were allowed to 
attach to poly-d-lysine–coated dishes (MatTek) for 2–3 h, and the media 
were supplemented with 12.5 mM Hepes, pH 7.5. Images were taken   
every 3 min for 3 h on an integrated microscope system (DeltaVision) using 
a PlanApo N60× oil objective (NA 1.42) and a 39.5°C environmental 
chamber (WeatherStation; Precision Control).317 Centrin-deficient centrosomes • Dantas et al.
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